Human Fibrinogen Concentrate
Fibryga® is a highly purified and pathogen inactivated human fibrinogen concentrate and an effective and convenient treatment for fibrinogen deficiency.
Fibryga® offers a number of benefits: concentration is standardised; it is stable at room temperature, can be reconstituted within minutes, and has a low infusion volume; there is no need for thawing or cross-matching blood type and it is double pathogen inactivated.
Treatment of bleeding and perioperative prophylaxis in patients with congenital hypo or afibrinogenaemia with bleeding tendency.1-3
Complementary therapy in the treatment of uncontrolled severe haemorrhage in patients with acquired fibrinogen deficiency.4
Fibryga® is presented in vials containing 1 g of fibrinogen as lyophilised powder for reconstitution with 50 mL sterile water for injection (WFI).1
After reconstitution, the solution provides approximately 20 mg/mL of human fibrinogen.
For intravenous administration via infusion or injection.
Do not store above 25 °C. Do not freeze. Keep the bottle in the outer carton to protect from light. The shelf life is two years at room temperature.
1. Fibryga® - Summary of Product Characteristics (EU)
2. Fibryga® - US PIL
3. Fibryga® - Canada monograph
4. Fibryga® - Summary of Product Characteristics (Switzerland)
You are now on Octapharma’s global website. Please select your country from the menu at the top of this page to access more detailed country-specific information or to contact your local Octapharma team.
Drug safety related information, such as adverse reactions, should be reported to firstname.lastname@example.org.